Effect of model-based dose-calculation algorithms in high dose rate brachytherapy of cervical carcinoma

被引:0
|
作者
Srivastava, Shraddha [1 ]
Venugopal, Ajay Kannathuparambil [2 ]
Singh, Moirangthem Nara [3 ]
机构
[1] King Georges Med Univ, Dept Radiotherapy, Lucknow, India
[2] Fortis Hosp, Dept Radiotherapy, New Delhi, India
[3] Reg Inst Med Sci, Dept Radiat Oncol, Imphal, Manipur, India
关键词
algorithms; brachytherapy; cervical cancer; Iridium-192; Monte Carlo Method; organs at risk; COLLAPSED CONE CONVOLUTION; BOLTZMANN-EQUATION SOLVER; CANCER BRACHYTHERAPY; MONTE-CARLO; RECOMMENDATIONS; TG-43; RADIOTHERAPY; VALIDATION; DOSIMETRY; IMPACT;
D O I
10.5603/rpor.100778
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: Task Group 43 (TG-43) formalism does not consider the tissue and applicator heterogeneities. This study is to compare the effect of model-based dose calculation algorithms, like Advanced Collapsed Cone Engine (ACE), on dose calculation with the TG-43 dose calculation formalism in patients with cervical carcinoma. Materials and methods: 20 patients of cervical carcinoma treated with a high dose rate of intracavitary brachytherapy were prospectively studied. The target volume and organs at risk (OARs) were contoured in the Oncentra treatment planning system (Elekta, Veenendaal, The Netherlands). All patients were planned with cobalt-60 (Co-60) and iridium-192 (Ir-192) sources with doses of 21 Gy in 3 fractions. These plans were calculated with TG-43 formalism and a model-based dose calculation algorithm ACE. The dosimetric parameters of TG-43 and ACE-based plans were compared in terms of target coverage and OAR doses. Results: For Co-60-based plans, the percentage differences in the D90 and V100 values for high-risk clinical target volume (HR-CTV) were 0.36 +/- 0.43% and 0.17 +/- 0.31%, respectively. For the bladder, rectum and sigmoid, the percentage differences for D2cc volumes were -0.50 +/- 0.51%, -0.16 +/- 0.53% and -0.37 +/- 1.21%, respectively. For Ir-192-based plans, the percentage difference in the D90 for HR-CTV was 0.54 +/- 0.79%, while V100 was 0.24 +/- 0.29%. For the bladder, rectum and sigmoid, the doses to 2cc volume were 0.35 +/- 1.06%, 0.99 +/- 0.74% and 0.74 +/- 1.92%, respectively. No significant differences were found in the dosimetric parameters calculated with ACE and TG-43. Conclusion: The ACE algorithm reduced doses to OARs and targets. However, ACE and TG-43 did not show significant differences in the dosimetric parameters of the target and OARs with both sources.
引用
收藏
页码:300 / 308
页数:9
相关论文
共 50 条
  • [1] Model-Based Dose Calculation Algorithms for Brachytherapy Dosimetry
    Enger, Shirin A.
    Vijande, Javier
    Rivard, Mark J.
    SEMINARS IN RADIATION ONCOLOGY, 2020, 30 (01) : 77 - 86
  • [3] Semiempirical dose-calculation models in brachytherapy
    Williamson, Jeffrey F.
    BRACHYTHERAPY PHYSICS, SECOND EDITION, 2005, (31): : 201 - 232
  • [4] Impact of a commercially available model-based dose calculation algorithm on treatment planning of high-dose-rate brachytherapy in patients with cervical cancer
    Abe, Kota
    Kadoya, Noriyuki
    Sato, Shinya
    Hashimoto, Shimpei
    Nakajima, Yujiro
    Miyasaka, Yuya
    Ito, Kengo
    Umezawa, Rei
    Yamamoto, Takaya
    Takahashi, Noriyoshi
    Takeda, Ken
    Jingu, Keiichi
    JOURNAL OF RADIATION RESEARCH, 2018, 59 (02) : 198 - 206
  • [5] High dose rate brachytherapy in the treatment of cervical carcinoma
    Stitt, JA
    HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA, 1999, 13 (03) : 585 - +
  • [6] Specification of absorbed dose to water using model-based dose calculation algorithms for treatment planning in brachytherapy
    Tedgren, Asa Carlsson
    Carlsson, Gudrun Alm
    PHYSICS IN MEDICINE AND BIOLOGY, 2013, 58 (08): : 2561 - 2579
  • [7] A Retrospective Dose Analysis of High-Dose Rate (HDR) Tandem and Ovoid and Interstitial Needle Cervical Brachytherapy Cases with a Model-Based Dose Calculation Algorithm (MBDCA)
    Radcliffe, B.
    Meltsner, S.
    Chang, Z.
    Chino, J.
    Huang, M.
    Craciunescu, O.
    MEDICAL PHYSICS, 2021, 48 (06)
  • [8] HIGH-DOSE-RATE BRACHYTHERAPY FOR CERVICAL-CARCINOMA
    STITT, JA
    THOMADSEN, BR
    FOWLER, JF
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1992, 24 (03): : 574 - 574
  • [9] High and low dose-rate brachytherapy for cervical carcinoma
    Orton, CG
    ACTA ONCOLOGICA, 1998, 37 (02) : 117 - 125
  • [10] High-dose-rate brachytherapy in uterine cervical carcinoma
    Patel, FD
    Rai, B
    Mallick, I
    Sharma, SC
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2005, 62 (01): : 125 - 130